ClearPoint Neuro, Inc. CLPT
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 10.98% | -10.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.98% | -10.29% | |||
| Cost of Revenue | 20.29% | -4.62% | |||
| Gross Profit | 5.20% | -13.49% | |||
| SG&A Expenses | -23.93% | 5.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.86% | 2.51% | |||
| Operating Income | 38.19% | -20.83% | |||
| Income Before Tax | 34.38% | -19.18% | |||
| Income Tax Expenses | 89.47% | -575.00% | |||
| Earnings from Continuing Operations | 34.20% | -18.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 34.20% | -18.69% | |||
| EBIT | 38.19% | -20.83% | |||
| EBITDA | 39.09% | -20.82% | |||
| EPS Basic | 35.92% | -16.24% | |||
| Normalized Basic EPS | 36.11% | -16.74% | |||
| EPS Diluted | 35.92% | -16.24% | |||
| Normalized Diluted EPS | 36.11% | -16.74% | |||
| Average Basic Shares Outstanding | 2.71% | 2.10% | |||
| Average Diluted Shares Outstanding | 2.71% | 2.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||